Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04463771
PHASE2

Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy.

Sponsor: Incyte Corporation

View on ClinicalTrials.gov

Summary

This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial cancer that has progressed on or after platinum-based chemotherapy. retifanlimab will be administered as monotherapy or in combination with other immunotherapy or targeted agents.

Official title: An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204)

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

206

Start Date

2021-01-26

Completion Date

2026-07-10

Last Updated

2025-12-10

Healthy Volunteers

No

Interventions

DRUG

retifanlimab

INCMGA00012 administered intravenously on Day 1 of each 28-day cycle for up to 26 cycles.

DRUG

epacadostat

epacadostat will be administered orally BID.

DRUG

pemigatinib

pemigatinib will be administered orally QD.

DRUG

INCAGN02385

INCAGN2385 will be administered every 2 weeks

DRUG

INCAGN02390

INCAGN2390 will be administered every 2 weeks

Locations (65)

Alaska Womens Cancer Care Akwcc

Anchorage, Alaska, United States

Honorhealth

Phoenix, Arizona, United States

Arizona Oncology Associates

Tucson, Arizona, United States

UCLA Medical Hematology & Oncology

Los Angeles, California, United States

Olive View Med Ctr

Sylmar, California, United States

Broward Health Medical Center

Fort Lauderdale, Florida, United States

Miami Cancer Institute

Miami, Florida, United States

Mount Sinai Medical Center Comprehensive Cancer Center

Miami Beach, Florida, United States

Advent Health Medical Group-Orlando 2501

Orlando, Florida, United States

H. Lee Moffitt Cancer Center and Research Institute Hospital

Tampa, Florida, United States

Georgia Cancer Center

Augusta, Georgia, United States

Barbara Ann Karmanos Cancer Hospital

Detroit, Michigan, United States

Minnesota Oncology-Maplewood

Coon Rapids, Minnesota, United States

Midwest Cancer Care

Kansas City, Missouri, United States

Washington University

St Louis, Missouri, United States

Billings Clinic Cancer Center

Billings, Montana, United States

Comprehensive Cancer Centers of Nevada

Henderson, Nevada, United States

New Mexico Cancer Care Alliance

Albuquerque, New Mexico, United States

Laura & Isaac Perlmutter Cancer Ctr

New York, New York, United States

University of North Carolina At Chapel Hill

Chapel Hill, North Carolina, United States

The Ohio State University Wexner Medical Center Division of Gynecologic Oncology

Hilliard, Ohio, United States

Willamette Valley Cancer Institute

Eugene, Oregon, United States

Texas Oncology-Tyler

Sioux Falls, South Dakota, United States

Tennessee Oncology

Nashville, Tennessee, United States

Texas Oncology-Austin Center

Austin, Texas, United States

Texas Oncology-Fort Worth South Henderson

Fort Worth, Texas, United States

Texas Oncology San Antonio

San Antonio, Texas, United States

Texas Oncology the Woodlands

Shenandoah, Texas, United States

Virginia Commonwealth University

Richmond, Virginia, United States

O.L.V Ziekenhuis

Aalst, Belgium

Institut Jules Bordet

Brussels, Belgium

Ghent University Hospital

Ghent, Belgium

Universitaire Ziekenhuis Leuven - Gasthuisberg

Leuven, Belgium

Centre Hospitalier Universitaire de Liege - Sart Tilman

Liège, Belgium

Chu Ucl Namur de Saint Elisabeth

Namur, Belgium

Chu Besancon Hospital Jean Minjoz

Besançon, France

Institut Bergonie

Bordeaux, France

Hospital Cochin Cancerologie

Paris, France

Cario - Centre Armoricain de Radiotherapie Imagerie Medicale Et Oncologie

Plérin, France

Centre de Lutte Contre Le Cancer - Institut de Cancerologie de L'Ouest - Rene Gauducheau

Saint-Herblain, France

Institut Gustave Roussy

Villejuif, France

High Technology Hospital Medcenter

Batumi, Georgia

Jsc Evex Hospitals

Kutaisi, Georgia

Todua Clinic, Llc

Tbilisi, Georgia

Caucasus Medical Centre Llc

Tbilisi, Georgia

INNOVA

Tbilisi, Georgia

Multiprofile Clinic Consilium Medulla Llc

Tbilisi, Georgia

Charite - Campus Virchow-Klinikum

Berlin, Germany

University Clinic Carl Gustav Carus Technical University Dresden

Dresden, Germany

Klinikum Kassel Gmbh

Kassel, Germany

Universitarsfrauenklinik Ulm

Ulm, Germany

Alexandra General Hospital of Athens

Athens, Greece

University Hospital of West Attica - Attikon

Athens, Greece

Hygeia Hospital

Marousi, Greece

Euromedica General Clinic of Thessaloniki

Thessaloniki, Greece

Azienda Ospedaliero-Universitaria Di Bologna Policlinico S. Orsola - Malpighi

Bologna, Italy

Presidio Ospedaliero Di Summa Antonio Perrino

Brindisi, Italy

Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori

Meldola, Italy

Istituto Di Ricovero E Cura A Carattere Scientifico (Irccs) Ospedale San Raffaele

Milan, Italy

Comitato Etico Fondazione Irccs Istituto Nazionale Dei Tumori Milano

Milan, Italy

European Institute of Oncology

Milan, Italy

Istituto Nazionale Tumori Irccs Fondazione Pascale

Naples, Italy

Iov - Istituto Oncologico Veneto Irccs

Padova, Italy

Fondazione Policlinico Universitario Agostino Gemelli Irccs

Roma, Italy

Ospedale Santa Maria Ca Foncello

Treviso, Italy